申请人:——
公开号:US20020006920A1
公开(公告)日:2002-01-17
A compound of the formula
1
wherein R
1
, R
2
and Q are as defined above, useful in the treatment of a condition selected from the group consisting of arthritis, cancer, tissue ulceration, macular degeneration, restenosis, periodontal disease, epidermolysis bullosa, sceritis, and other diseases characterized by matrix metalloproteinase activity, AIDS, sepsis, septic shock and other diseases involving the production of TNF. In addition, the compounds of the present invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (NSAID'S) and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-platinum, etoposide, taxol, taxotere and other alkaloids, such as vincristine, in the treatment of cancer.
一种化合物的公式1,其中R1,R2和Q的定义如上所述,可用于治疗以下疾病:关节炎,癌症,组织溃疡,黄斑变性,再狭窄,牙周病,表皮溶解性水泡病,巩膜炎和其他以基质金属蛋白酶活性为特征的疾病,艾滋病,败血症,脓毒性休克和其他涉及TNF产生的疾病。此外,本发明的化合物可与标准非甾体类抗炎药(NSAID)和镇痛药一起使用,并与细胞毒性药物(如阿霉素、多柔比星、顺铂、依托泊苷、紫杉醇、替加氟等生物碱,如长春新碱)结合使用,用于治疗癌症。